54Y-17793-34246
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 764 / TX
- Registered
- 2021-07-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-09
Registered in v-safe
-
2021-07-09
Dose 1 — Pfizer-BioNTech
- 2021-07-09
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-23
- 2021-07-30
-
2021-08-02
Dose 2 — Pfizer-BioNTech
- 2021-08-02
-
2021-08-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-09
- 2021-08-16
- 2021-08-23
- 2021-09-01
- 2021-09-06
-
2021-09-13
Survey response — day 42, dose 2MedDRA: Dyspnoea, Headache, Pain — Feeling: FairFree text: Some loss of breath, headaches, and body aches (could be pregnancy related).MedDRA releases: 2024-11 · check-in free text available
- 2022-01-31
-
2022-08-02
Survey response — 12 months, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive for COVID July 6, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-08-02
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-09 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-02 | Unsuccessful |
Free text
Release 9 — day 42, dose 2
Symptoms: Some loss of breath, headaches, and body aches (could be pregnancy related).
Release 12 — 12 months, dose 2
Symptoms: Tested positive for COVID July 6, 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release